1. Medtech Insight
  2. >>Geography
  3. >>Europe
  4. >>United Kingdom

UK Into 2019: Health-Tech Adoption Not Far From The 'Tipping Point'

 
• By Ashley Yeo

The UK's future economic relationship with the EU consumed more than its fair share of headlines in 2018. But within UK health care, at ground level, Brexit was often missing entirely from main conference agendas, as stakeholders sought to both maximize current operating conditions and prepare for future health-care architectures and evolving innovation systems. That was the case at Medtech Futures, in Cambridge, UK, this fall.

uk flag close up

As 2018 turns to 2019, the future may be unpredictable for those working in the UK health-care ecosystem, with budgetary pressures on the system higher than ever, greater demand for services, the unknown perils of Brexit and the associated talent shortage, and systemic care staff shortages. That is not to mention a whole new regulatory system for medical technology in the EU, of which, at the time of writing, the UK still remains a part.

Nevertheless, in this fog of uncertainty, there remain bright spots for UK health-care stakeholders, as both industry and the government...

More from United Kingdom

Medtechs Wait For Dividend As UK Spending Review Prioritizes Healthcare And NHS

 
• By Ashley Yeo

Increased support for NHS services and delivery infrastructure announced in the 11 June government spending review by chancellor of the exchequer Rachel Reeves could boost inward investment and offer new market opportunities for medtechs.

UK Healthtech Center Of Excellence Given Key MHRA Digital Regulation Role

 
• By Ashley Yeo

Ahead of the 11 June UK spending review and its anticipated funding uplift for healthcare and life sciences, the MHRA announced an expansion of its digital expertise by creating a dedicated hub in Leeds, a renowned center of medtech excellence.

Aneira Health Launches New Precision Medicine Platform Exclusively For Women

 
• By Natasha Barrow

Cecilia Lindgren, Aneira Health’s co-founder and chief science officer, said that the company has “redesigned the diagnostic model.” The subscription-based platform offers clinical-grade and AI diagnostics alongside clinical consultation.

UK Take Care! Regulatory And Market Access Reforms Must Not Shut Out Medtech Growth

 
• By Ashley Yeo

Speakers at a recent UK medtech outlook conference voiced optimism about the sector’s prospects, but warned that cost burdens, over-regulation and lengthy processes will impede the capacity of local SMEs to innovate. Only 10% of NHS procured medtech comes from UK manufacturers.

More from Europe